Literature DB >> 27324645

Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.

Jérôme Peyrou1, Patricia Réant2, Amélie Reynaud2, Claire Cornolle2, Marina Dijos2, Caroline Rooryck-Thambo3, Mathieu Landelle2, Michel Montaudon4, François Laurent4, Raymond Roudaut2, Stéphane Lafitte2.   

Abstract

To evaluate if morphological or functional abnormalities could be detected with echocardiography in hypertrophic myocardiopathy (HCM) mutation carriers without left ventricle (LV) hypertrophy has developed. HCM is caused by extensive genes mutations found in two-third of patients. Because screening for carriership of a large population is unreasonable, identification of asymptomatic subjects is confined to the use of imaging such as echocardiography, by which subtle abnormalities can be detected. Comprehensive echocardiographic studies including morphological and functional assessment were performed. Asymptomatic HCM mutation carriers without hypertrophy (Phe-/Gen+, n = 14), and HCM patients (Phe+/Gen+, n = 17) were compared with healthy control subjects (n = 32) in a prospective design. Compared to controls, septum thickness was significantly higher with an elongated mitral valve in both groups. Thickened LV muscular band (LVMB) are more likely found in Phe-/Gen+ and Phe+/Gen+. The thickness of LVMB was higher in the Phe-/Gen+ versus controls. A LVMB thickness ≥3.6 mm was associated with HCM mutation carriership (sensitivity: 76.9 %, specificity: 94.1 %). The regional strain was significantly impaired in the basal segments of the septum in the Phe-/Gen+. The GLS was significantly impaired in the Phe+/Gen+ (-16.4 % ± 2.9 vs. -21.4 % ± 2.3 in control subjects, p = 0.01). Mitral A wave velocity, septal E/e', averaged E/e' were increased in both groups. E/A ratio was significantly lower in Phe+/Gen+. Morphological and functional abnormalities in hypertrophy-free HCM mutation carriers could be detected with echocardiography. Anomalous thickened LVMB could be representing a morphological marker for the HCM disease without overt hypertrophy has developed or in patients with an ambiguous diagnosis.

Entities:  

Keywords:  Echocardiogaphy; Genetics; Hypertrophic cardiomyopathy; Hypertrophy; Morphology; Myocardial function

Mesh:

Year:  2016        PMID: 27324645     DOI: 10.1007/s10554-016-0929-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  29 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

Review 3.  The relevance of left ventricular bands.

Authors:  B Darazs; H R Taylor; A L van Gelder
Journal:  S Afr Med J       Date:  1988-07-16

4.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

5.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

6.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

7.  Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.

Authors:  Olivier Cazorla; Szabolcs Szilagyi; Nicolas Vignier; Guillermo Salazar; Elisabeth Krämer; Guy Vassort; Lucie Carrier; Alain Lacampagne
Journal:  Cardiovasc Res       Date:  2005-12-27       Impact factor: 10.787

8.  Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis.

Authors:  Stéphane Lafitte; Matthieu Perlant; Patricia Reant; Karim Serri; Herve Douard; Anthony DeMaria; Raymond Roudaut
Journal:  Eur J Echocardiogr       Date:  2008-11-07

9.  How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.

Authors:  Tjeerd Germans; Iris K Rüssel; Marco J W Götte; Marieke D Spreeuwenberg; Pieter A Doevendans; Yigal M Pinto; Rob J van der Geest; Jolanda van der Velden; Arthur A M Wilde; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-15       Impact factor: 5.364

10.  Left ventricular bands. A normal anatomical feature.

Authors:  L M Gerlis; H M Wright; N Wilson; F Erzengin; D F Dickinson
Journal:  Br Heart J       Date:  1984-12
View more
  8 in total

1.  Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers?

Authors:  Gloria Maria Santambrogio; Alessandro Maloberti; Paola Vallerio; Angelica Peritore; Francesca Spanò; Lucia Occhi; Francesco Musca; Oriana Belli; Benedetta De Chiara; Francesca Casadei; Rita Facchetti; Fabio Turazza; Emanuela Manfredini; Cristina Giannattasio; Antonella Moreo
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-18       Impact factor: 2.357

2.  Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.

Authors:  John D Groarke; Patrycja Z Galazka; Allison L Cirino; Neal K Lakdawala; Jens J Thune; Henning Bundgaard; E John Orav; Robert A Levine; Carolyn Y Ho
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-10-01       Impact factor: 6.875

3.  The co-segregation of the MYL2 R58Q mutation in Chinese hypertrophic cardiomyopathy family and its pathological effect on cardiomyopathy disarray.

Authors:  Kunlun Yin; Yi Ma; Hao Cui; Yang Sun; Bianmei Han; Xuewen Liu; Kun Zhao; Wenke Li; Jingjin Wang; Hongyue Wang; Shuiyun Wang; Zhou Zhou
Journal:  Mol Genet Genomics       Date:  2019-05-18       Impact factor: 3.291

Review 4.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  Characterization of hypertrophic cardiomyopathy according to global, regional, and multi-layer longitudinal strain analysis, and prediction of sudden cardiac death.

Authors:  Marie-Philippe Vergé; Hubert Cochet; Amélie Reynaud; Lucas Morlon; Jérôme Peyrou; Cécile Vincent; Caroline Rooryck; Philippe Ritter; Stéphane Lafitte; Patricia Réant
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-27       Impact factor: 2.357

Review 6.  The role of echocardiography in management of hypertrophic cardiomyopathy.

Authors:  Trine F Haland; Thor Edvardsen
Journal:  J Echocardiogr       Date:  2019-12-19

7.  Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.

Authors:  Hannah G van Velzen; Arend F L Schinkel; Myrthe E Menting; Annemien E van den Bosch; Michelle Michels
Journal:  J Ultrasound       Date:  2018-06-06

8.  The systolic paradox in hypertrophic cardiomyopathy.

Authors:  Trine F Haland; Nina E Hasselberg; Vibeke Marie Almaas; Lars A Dejgaard; Jørg Saberniak; Ida S Leren; Knut Erik Berge; Kristina H Haugaa; Thor Edvardsen
Journal:  Open Heart       Date:  2017-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.